Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Trinity Biotech

This article was originally published in The Gray Sheet

Executive Summary

Trinity Biotech: Acquires infectious disease and autoimmune diagnostic kit manufacturer Clark Laboratories for approximately $6.2 mil. in stock and cash. Trinity will issue 1.4 mil. shares of common stock in exchange for all of Clark's outstanding shares. Approximately two-thirds of the issued shares will be subject to a one-to-two-year "lock up" and can be bought back by Trinity at any time over the next two years at a premium ranging from 13% to 25% of the issued price, Trinity explains. Clark preferred stock will be redeemed by Trinity for approximately $1.5 mil. in cash. Jamestown, New York-based Clark had income of $237,000 on sales of $3.9 mil. for the 1996 fiscal year. With the acquisition, Trinity gains a 7% stake in CLI Oncology and an exclusive supply agreement with Wampole Laboratories to supply Clark's full range of diagnostic kits...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel